Ryman Healthcare Limited (RYHTY)
OTCMKTS · Delayed Price · Currency is USD
7.11
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
Ryman Healthcare Market Cap
Ryman Healthcare has a market cap or net worth of $1.59 billion as of October 17, 2025. Its market cap has decreased by -15.50% in one year.
Market Cap
1.59B
Enterprise Value
2.56B
Revenue
430.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.11
Market Cap Chart
Since June 6, 2000, Ryman Healthcare's market cap has increased from 81.02M to 1.59B, an increase of 1,860.87%. That is a compound annual growth rate of 12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.59B | -12.21% |
| Dec 31, 2024 | 1.81B | -29.31% |
| Dec 29, 2023 | 2.56B | 49.85% |
| Dec 30, 2022 | 1.71B | -59.03% |
| Dec 31, 2021 | 4.17B | -23.30% |
| Dec 31, 2020 | 5.44B | -0.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |